Home  >  Products  >  EEA1 (early endosome antigen 1) Blocking Peptide (the N terminal of EEA1)(100ug)
EEA1 (early endosome antigen 1) Blocking Peptide (the N terminal of EEA1)(100ug)

EEA1 (early endosome antigen 1) Blocking Peptide (the N terminal of EEA1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-EEA1 Antibody(ARP58126_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP58126
Size: 100ug
Weight: 162kDa
Gene: 8411
Format: Lyophilized powder
Target: EEA1 is involved in neuronal synaptic vesicle function and axonal transport and growth. EEA1 may undergo calcium-dependent conformational changes that are required for binding to SNAP-25.
Alternative names: ZFYVE2
See Full Product Listings >